Karekind Pharmaceutical Private Limited
About Karekind Pharmaceutical Private Limited
Data last updated:
Karekind Pharmaceutical Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2013PTC056519. Its GSTIN is 09AAFCK4701J1ZI (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saghir Khan Ahmad and Ishrat Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 105 Umang Part II Mahanagar, Bareilly, Uttar Pradesh, India – 243001.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.21 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹18,697 (net margin 0.2%) and EBITDA of ₹32,238 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Karekind Pharmaceutical Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address105 Umang Part II Mahanagar, Bareilly, Uttar Pradesh, India – 243001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Karekind Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Karekind Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Karekind Pharmaceutical Private Limited, buy the company report.
Financials of Karekind Pharmaceutical Private Limited
FY 2025 filings availableKarekind Pharmaceutical Private Limited reported revenue of ₹80.21 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32,238 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18,697 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Karekind Pharmaceutical Private Limited, buy the company report.
Board of directors of Karekind Pharmaceutical Private Limited
Karekind Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saghir Khan Ahmad | Director | 26 Apr 2013 | 13 Years 6 Months | Current |
| Ishrat Khan | Director | 09 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Karekind Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sha Traders Private Limited | ₹80.24 Lakh (FY 2025) | 9.0% | New Delhi, Delhi, India | |||
| Two-Sheaf Computers Private Limited | ₹80.24 Lakh (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Revfix Tech Private Limited | ₹80.24 Lakh (FY 2024) | -80.0% | Delhi, India | |||
| Akalpya Healthcare Private Limited | ₹80.22 Lakh (FY 2024) | 40.0% | Thaltej, Gujarat, India | |||
| Kabaria Hospitality Private Limited | ₹80.22 Lakh (FY 2024) | -12.0% | Ahmedabad, Gujarat, India | |||
| Karekind Pharmaceutical Private Limitedthis company | ₹80.21 Lakh (FY 2025) | ₹18,697 | 0.2% | -11.0% | Bareilly, Uttar Pradesh, India | |
| Airace Technologies Private Limited | ₹80.21 Lakh (FY 2024) | -30.0% | Bangalore, Karnataka, India | |||
| Pinnacle Infovision Private Limited | ₹80.2 Lakh (FY 2017) | -17.0% | Navi Mumbai, Maharashtra, India | |||
| Samaston Ventures Private Limited | ₹80.19 Lakh (FY 2024) | 7.0% | Santacruz West, Maharashtra, India | |||
| Aadhya Instruments India Private Limited | ₹80.19 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| Viewlink Marcom Private Limited | ₹80.18 Lakh (FY 2025) | -59.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Karekind Pharmaceutical Private Limited, buy the company report.
Auditor
Karekind Pharmaceutical Private Limited is audited by AMBER ASAD & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMBER ASAD & CO. | FY 2017 | 014990C |
Shareholding
The shareholding of Karekind Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Karekind Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Karekind Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Karekind Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Karekind Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCK4701J1ZI | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Karekind Pharmaceutical Private Limited, buy the company report.
Recent activity
Karekind Pharmaceutical Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Aijaz Ahmad ceased to be Director on 11 Apr 2024.
Frequently asked questions
Karekind Pharmaceutical is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 April 2013 (13+ years old) and is registered under CIN U74120UP2013PTC056519.
Karekind Pharmaceutical has 2 current directors:
- Saghir Khan Ahmad - Director
- Ishrat Khan - Director
The latest financial statements of Karekind Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Karekind Pharmaceutical is 09AAFCK4701J1ZI, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Karekind Pharmaceutical is U74120UP2013PTC056519. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Karekind Pharmaceutical was incorporated on 26 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Karekind Pharmaceutical by revenue are Sha Traders Private Limited, Two-Sheaf Computers Private Limited, Revfix Tech Private Limited, Akalpya Healthcare Private Limited, Kabaria Hospitality Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Aijaz Ahmad ceased to be Director on 11 Apr 2024. Ishrat Khan was appointed as Director on 09 Apr 2024. Devendra Mohan Saxena ceased to be Director on 07 Jul 2018. Karekind Pharmaceutical has 4 board changes on record in total.
The registered office of Karekind Pharmaceutical is at 105 Umang Part II Mahanagar, Bareilly, Uttar Pradesh, India – 243001.
Karekind Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Karekind Pharmaceutical is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
